Manufacturers must prove that new drug products are free of cancer-causing impurities

How did the NIH get it so wrong – and how can it move on?

Rising drug prices are not helping the industry’s image problem.

The biopharmaceutical sector is rapidly evolving – can your supply chain keep up?

Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.

The feel of a topical formulation can make a big difference to compliance.

Pharmaceutical and regulatory professionals around the world must speak the same language.

Meet the award-winning researchers making affordable malaria medicine a reality.

It's time to get off the fence and get on board with continuous manufacturing.

Is pharma keeping up with the latest innovations? US legislators say no, and are looking to a new act to accelerate approvals.